Innovent Biologics jumps most in 3 weeks on robust product revenue growth

Innovent Biologics

05/08/2026 02:52

** Shares of Innovent Biologics Inc 1801.HK jump 6.3% to HK$92.2, on track for the biggest one-day pct gain since July 15
** Stock touches the highest level since July 24 in the second session of gain
** The innovative medicine developer and producer says its first half 2026 product revenue exceeds 8.2 bln yuan ($1.21 bln), up over 55% y/y, of which total revenue for the second quarter is up 60% y/y to over 4.3 bln yuan
** YTD, stock up 18%, Hang Seng Biotech Index .HSBIO up 0.6%
     
     
     
     
($1 = 6.7532 Chinese yuan renminbi)

(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))